Abstract
KW-1070, a new member of a series of aminoglycoside antibiotics, was applied to the treatment of five patients with respiratory infections.
The drug was administered intramuscularly, at a daily dose of 400mg-800mg six to fifteen days.
The results obtained were good in four cases, and unassessable in one case due to the lack of inflammatory symptoms. No side effects were observed.